ATC Group: V09AA Technetium (99mTc) compounds

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of V09AA in the ATC hierarchy

Level Code Title
1 V Various
2 V09 Diagnostic radiopharmaceuticals
3 V09A Central nervous system
4 V09AA Technetium (99mTc) compounds

Group V09AA contents

Code Title
V09AA01 Technetium (99mTc) exametazime
V09AA02 Technetium (99mTc) bicisate

Active ingredients in V09AA

Active Ingredient Description
Technetium ⁹⁹ᵐTc bicisate
Technetium ⁹⁹ᵐTc exametazime

When technetium Tc 99m pertechnetate is added to exametazime in the presence of stannous reductant, a lipophilic technetium Tc 99m complex is formed. This lipophilic complex is the active moiety. The lipophilic technetium Tc 99m exametazime complex is taken up and retained in leukocytes. It is used for leukocyte (white blood cell) labeled scintigraphy as an adjunct in the localization of intra-abdominal infection and inflammatory bowel disease.

Related product monographs

Title Information Source Document Type  
CERETEC Powder for solution for injection FDA, National Drug Code (US) MPI, US: SPL/Old
ULTRA-TECHNEKOW FM Radionuclide generator Health Products Regulatory Authority (IE) MPI, EU: SmPC